Effects of prednisolone and dexamethasone on alkali burns of the esophagus in rabbit.
Steroids have been widely used to prevent the severe secondary strictures that inevitably follow accidental ingestion of caustic substances by children, though with controversial results. To confirm the efficacy of large early doses of dexamethasone, we conducted an experimental study in rabbits. A cotton swab soaked in sodium hydroxide was placed on the esophageal mucosa of 30 rabbits. The rabbits were then treated with antibiotics and randomly allocated to one of three groups. One group received no steroids; the second group was treated with prednisolone; and the third was given dexamethasone. After 21 days, the rabbits were killed and the severity of the lesion was evaluated by radiological, anatomical, and histological examination. Rabbits with moderate or severe stricture, as defined on the basis of radiological examination, made up 80% of the control group, 70% of the prednisolone-treated group, and 40% of the dexamethasone-treated group. Rabbits with third-degree burns, with or without macroscopic ulcers, made up 60% of the control group, 40% of the prednisolone-treated group, and 30% of the dexamethasone-treated group. On histological examination, rabbits with third-degree lesions made up 70% of the control group, 40% of the prednisolone-treated group, and only 20% of the dexamethasone-treated group. Only the difference between the control and dexamethasone-treated group was statistically significant. Taken together, our results clearly indicate that, in rabbits, rapid postburn administration of dexamethasone leads to significant reductions in the frequency and severity of strictures and in the severity of burns.
Bautista
A
A
Pediatrics Department, General Hospital of Galicia, University of Santiago, SERGAS, La Coruña, Spain.
Tojo
R
R
Varela
R
R
Estevez
E
E
Villanueva
A
A
Cadranel
S
S
D000818:Animals; D002057:Burns, Chemical; D003907:Dexamethasone / Q000627:therapeutic use*; D004940:Esophageal Stenosis / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control*; D004947:Esophagus / Q000000981:diagnostic imaging / Q000473:pathology; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use*; D011817:Rabbits; D011859:Radiography; D012972:Sodium Hydroxide
D012972:Sodium Hydroxide; D003907:Dexamethasone; D011239:Prednisolone